Publications List

An agentic AI framework connecting language models to electronic health records and a biomedical knowledge graph for real-world evidence.

Bellucci G, Gu W, Rose PW, Baranzini SE

Frontiers in artificial intelligence
2026
Deep active learning-based experimental design to uncover synergistic genetic interactions for host-targeted therapeutics.

Zhu H, Silva M, Cadena J, Soper B, Lisicki M, Peetoom B, Baranzini SE, Sundaram S, Ray P, Drocco J

Bioinformatics advances
2026
The Gut Microbiome in Multiple Sclerosis.

Sánchez-Sanz A, Baranzini SE

Neurology(R) neuroimmunology & neuroinflammation
2026
Circulating Short-Chain Fatty Acid Profile Predicts Functional Outcome After Moderate-to-Severe Traumatic Brain Injury.

Lieberman OJ, Nittala S, Rojas-Valencia L, Baranzini SE, Singhal NS, Hemphill JC, Amorim E, Ferguson AR, Hinson HE

Critical care explorations
2026
Microbiome-derived metabolites from vitamin B2 and B9 pathways modulate MAIT cells from multiple sclerosis patients.

Correale J, Marrodan M, Piedrabuena MA, Soman K, Farez MF, Baranzini SE

Multiple sclerosis (Houndmills, Basingstoke, England)
2026
Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence".

Cerono G, Cree BAC, Hauser SL, Baranzini SE

Annals of neurology
2026
The genetics of multiple sclerosis: an updated perspective.

Bellucci G, Baranzini SE

Current opinion in neurology
2026
Female-enriched Eggerthella lenta drives neuroinflammation and IFN-γ via host receptor TLR2.

Rock RR, Alexander M, Noecker C, Trepka KR, Upadhyay V, Ortega EF, Ramirez L, Siewert L, Olson CA, Halsey T, Pröbstel AK, Baranzini SE, Turnbaugh PJ

bioRxiv : the preprint server for biology
2026
Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence".

Cerono G, Cree BAC, Hauser SL, Baranzini SE

Annals of neurology
2026
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis.

Gacem N, Bezukladova S, Windener F, Karam T, Ottoboni L, Brambilla E, Ruffini F, Soman K, Garcia-Diaz B, Levy MJF, Cui QL, Formato A, Deboux C, Chazot J, Panic R, Albrecht S, Yilmaz EN, González RG, Eberini I, Olla S, Bresciani A, Goebels N, Zipp F, Agresti C, Antel J, Evercooren AB, Kuhlmann T, Baranzini SE, Panina-Bordignon P, Nait-Oumesmar B, Martino G

Science translational medicine
2026